Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
about
To Screen or not to Screen: Low Dose Computed Tomography in Comparison to Chest Radiography or Usual Care in Reducing Morbidity and Mortality from Lung CancerImplementation and organization of lung cancer screeningRisk factors assessment and risk prediction models in lung cancer screening candidatesPulmonary nodules and CT screening: the past, present and futurePopulation-based screening for cancer: hope and hype.Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practiceReproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan IntervalCons: long-term CT-scan follow-up is not the standard of care in patients curatively treated for an early stage non-small cell lung cancer.Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-AnalysisAn official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.Diagnosis of Lung Cancer by Fractal Analysis of Damaged DNALung nodule and cancer detection in computed tomography screening.Research in progress--LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk groupRadiological and pathological analysis of LDCT screen detected and surgically resected sub-centimetre lung nodules in 44 asymptomatic patients.Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.Missed lung cancer: when, where, and why?Necessity of organized low-dose computed tomography screening for lung cancer: From epidemiologic comparisons between China and the Western nations.AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future.Lung cancer screening: utility of molecular applications in conjunction with low-dose computed tomography guidelines.Efficacy of low-dose computed tomography screening for lung cancer: the current state of evidence of mortality reduction.Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.Implementation of lung cancer CT screening in the Nordic countries.Analysis of the incidence and factors predictive of outcome in patients with head and neck cancer with pulmonary nodules.Patients with a Previous History of Malignancy Undergoing Lung Cancer Screening: Clinical Characteristics and Radiologic FindingsProportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer ScreeningReply: Lung Cancer Susceptibility, Ethnicity, and the Benefits of Computed Tomography Screening.Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.Progress and prospects of early detection in lung cancer.Reconsidering lung cancer screening: is biannual screening possible?Status of lung cancer screening.Analysis of morphological changes after facial massage by a novel approach using three-dimensional computed tomography.Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.Screening for Lung Cancer. Improving Outcomes with Better Patient Selection.Cause-specific mortality in HPV+ and HPV- oropharyngeal cancer patients: insights from a population-based cohort.Lung Cancer Screening in the Post-National Lung Screening Trial Era: Applying Screening in the Real World.Volume doubling time of lung cancer detected in idiopathic interstitial pneumonia: comparison with that in chronic obstructive pulmonary disease.Usefulness of near-infrared angiography for identifying the intersegmental plane and vascular supply during video-assisted thoracoscopic segmentectomy.British Thoracic Society guidelines for the investigation and management of pulmonary nodules.
P2860
Q26744809-376240AE-8D6B-410F-A837-07184EBD0290Q26747805-059097F5-0E30-4B6E-A3BD-7A60C8B82111Q26747819-73B2BC86-82BC-4024-AFEA-5B86DD4E84DCQ26766010-9ECF5F59-25C4-4C46-BBF9-70B8E4165D13Q30251601-6109DDF1-2EF2-4014-9045-FBD12A71E6FAQ33908633-7053DDA5-1F93-4270-9CA5-828D8CD39CC7Q35778736-107B2A2E-7DDB-495A-BE5C-30856CB238D3Q35996056-4E8217E6-0144-4039-A561-EB0C95EE2A6BQ36162615-7A644B2A-6019-49ED-B35A-1E4D1365D6CFQ36185930-BF718F65-0678-4D88-8B3E-A5E8DE7DAD41Q36204319-F4F5F8FB-AAD0-49FF-A9EB-E717D4BC5C28Q36303690-A50CBC0B-9A00-4495-BD3C-4C7EB0DD9DE1Q36475686-96765899-8BAF-4405-99E2-3C29BAB20638Q37191595-CAA859E0-9E79-4C9A-BA7E-68A355AD394AQ37390938-63601C24-B760-497B-A2C2-7B76A0E3B1FCQ37580040-D61CF3F4-06AC-4FFA-9262-802C5D11E056Q37682457-E38BC094-081B-4660-84DC-89B98D747A05Q37702170-84D9106B-4A3A-499F-964D-195E83AC5D02Q38689104-679991CA-AD1B-4E92-8600-28C12C79EB33Q38718638-F8E677BA-C14A-4327-B5C6-8677986C9B12Q38999265-ABD7F1CC-8ED5-4523-ABEA-66965F533813Q39066771-0CD1FE39-768C-4E55-A2F2-1A93C3E56D0AQ39344447-909D0BAE-2C7A-4B47-AD25-DDBC9D356934Q39457070-4111EEE9-AF7D-4740-9AC7-9ACC49260E1FQ39737322-9C7DD0EC-5878-4327-A4E5-ADAA09F9583BQ40000722-82D32654-B2D8-4FE0-8DFC-0063B1E076A5Q40256601-A6FB98C6-F9AD-4041-B36B-AB98F74352A4Q40914963-43AD48B0-E880-4833-A444-CDECC334C8A9Q41521258-7F82A805-205A-4DD4-A211-0745B0B147B5Q42139806-B32F82E9-41EC-43FF-99CD-266B10BE4980Q42384619-61F11B39-9E7C-4911-B1D0-225C4D1EDCA5Q47138829-B187CDF0-54EB-450F-9DE8-CD3948AA1314Q47937777-CF207CA0-042B-4282-8F72-BF93721B13C5Q47986975-2BDFDF76-2EC8-45A7-AC64-949573302517Q48062376-2A1D8515-3546-4FCF-8862-374DA4A53F49Q48242352-2F16085D-4712-4069-B3AA-C1F002B7D56BQ48546834-D725B04F-DA63-4A8C-BB83-D388555607ADQ50077821-4E996F4F-91D1-4446-ADF8-57B4105C4CB8Q50096516-6BFF0EC4-2785-405C-9660-408557F1573CQ51621075-15397F08-BE70-44B8-9DD5-17ACD9414572
P2860
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Detection of lung cancer throu ...... formance and interval cancers.
@en
Detection of lung cancer through low-dose CT screening
@nl
type
label
Detection of lung cancer throu ...... formance and interval cancers.
@en
Detection of lung cancer through low-dose CT screening
@nl
prefLabel
Detection of lung cancer throu ...... formance and interval cancers.
@en
Detection of lung cancer through low-dose CT screening
@nl
P2093
P1433
P1476
Detection of lung cancer throu ...... rformance and interval cancers
@en
P2093
Carla Weenink
Carlijn M van der Aalst
Erik Thunnissen
Ernst Th Scholten
Harry J de Koning
Jan-Willem J Lammers
Kristiaan Nackaerts
Marjolein A Heuvelmans
Matthijs Oudkerk
Pim A de Jong
P304
P356
10.1016/S1470-2045(14)70387-0
P577
2014-10-01T00:00:00Z